O'Callaghan, G., & Houston, A. (2015). Prostaglandin E2 and the EP receptors in malignancy: Possible therapeutic targets? British Journal of Pharmacology, 172(22), 5239. https://doi.org/10.1111/bph.13331
Chicago Style (17th ed.) CitationO'Callaghan, G., and A. Houston. "Prostaglandin E2 and the EP Receptors in Malignancy: Possible Therapeutic Targets?" British Journal of Pharmacology 172, no. 22 (2015): 5239. https://doi.org/10.1111/bph.13331.
MLA (9th ed.) CitationO'Callaghan, G., and A. Houston. "Prostaglandin E2 and the EP Receptors in Malignancy: Possible Therapeutic Targets?" British Journal of Pharmacology, vol. 172, no. 22, 2015, p. 5239, https://doi.org/10.1111/bph.13331.
Warning: These citations may not always be 100% accurate.